Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2016 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (233)	9/24/2016 3:34:00 AM
From: markdevera92	1 Recommendation Recommended By Thehammer Read Replies (1) \| Respond to of 311

HI bulba Is it possible for you to publish the whole ranking of all players so we can see where we rank? thanks mark

To: BulbaMan who wrote (233)	9/30/2016 6:18:52 PM
From: BulbaMan	Read Replies (1) \| Respond to of 311

9/30/16 Contest update When the “Big Debate” finally ended only Trump’s sniffling had anyone thinking about drugs; e.g., cnn.com Still, despite no hectoring by Hillary about high drug prices, it was not a huge week for biotech stocks. At Friday’s close, the Contest median was down -15.93% YTD (vs. down -15.26% YTD a week ago), the Nasdaq Biotech Index (NBI) was down -14.50% YTD (vs. down -11.92% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was down -5.68% YTD (vs. down -2.99% YTD a week ago). The Nasdaq Composite Index (NCI) was up 6.08% YTD (vs. up 5.96% YTD a week ago). JBOG’s portfolio, up 32.35% YTD, remained in first place, but second place DNAJOE’s portfolio, up 31.28% YTD, almost grabbed the lead getting a boost from both AUPH & GWPH. STEVEL’s portfolio, up 11.37% YTD, had a good week and moved in to third place . At Friday’s close, 9 of the 58 Contest portfolios were in the green, with 25 portfolios beating the NBI and 14 beating the SPSIBI. The 223 Contest stock picks had an average YTD loss of -9.24% and a median YTD loss of -20.00%, with 68 of the 223 Contest portfolio stocks up for the year. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week, ranked by % Gained and % Lost. (Prices not converted to US$ in these Tables.) Portfolio adjustments: MDVN buyout by Pfizer at $81.50 per share closed. I reallocated proceeds using 9/30/16 closing prices. Only a single portfolio, BMAZ, held MDVN. (All corrections, especially adjustments for splits, greatly appreciated.) I will post Q3 closing data shortly. Enjoy the first October weekend biotechies! And to those who celebrate Rosh Hashanah, all the best for a sweet 5777! Peace & good health, Bulba 9/30/16 Rank Name Profit/Loss 1 JBOG 32,352 2 DNAJOE 31,278 3 STEVEL 11,368 4 USUBAN 9,829 5 THEOX 7,343 6 BIOPLAY 4,604 7 MASTER 4,309 8 GHMM 3,517 9 DEWDIL 1,558 10 BAGEL -554 Week's Top 5 Gainers Symbol 9/23/16 9/30/16 Wk.%chg. ARRY 3.65 6.75 84.93% CATB 4.36 6.16 41.28% AUPH 2.40 3.01 25.42% GWPH 107.56 132.73 23.40% GBIM 1.02 1.25 22.55% Week's Worst 5 Losers Symbol 9/23/16 9/30/16 Wk.%chg. ADHD 4.65 2.47 -46.88% ATNM 1.79 1.35 -24.58% SSH 0.72 0.56 -22.22% OPHT 58.140 46.130 -20.66% MRNS 2.22 1.82 -18.02%